Mercator MedSystems
Home
About Us
Corporate Mission
Officers and Directors
Products
Bullfrog Micro-Infusion Device
Blowfish Transbronchial Micro-Infusion Device
Science and Technology
Peripheral Artery Disease
Bronchial Carcinoma
Peer-Reviewed Publications
Clinical Trials
TANGO
LIMBO
DANCE
BROADWAY
Other Trials
News
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris
MedTech Strategist Nov 27, 2017
Mercator MedSystems Announces Completion of Enrollment in the LIMBO-ATX Trial
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at ISET and LINC
Mercator Bullfrog Device Being Used in New Proteon Therapeutics Study
Late-Breaking Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at VIVA 2016
LIMBO-ATX Trial Begins in United States
LIMBO-PTA Trial Begins in Germany
Trent Reutiman Named CEO
Archives
Contact
Home
/
About Us
/
Corporate Mission
Officers and Directors
Products
/
Bullfrog Micro-Infusion Device
Blowfish Transbronchial Micro-Infusion Device
Science and Technology
/
Peripheral Artery Disease
Bronchial Carcinoma
Peer-Reviewed Publications
Clinical Trials
/
TANGO
LIMBO
DANCE
BROADWAY
Other Trials
News
/
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris
MedTech Strategist Nov 27, 2017
Mercator MedSystems Announces Completion of Enrollment in the LIMBO-ATX Trial
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at ISET and LINC
Mercator Bullfrog Device Being Used in New Proteon Therapeutics Study
Late-Breaking Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at VIVA 2016
LIMBO-ATX Trial Begins in United States
LIMBO-PTA Trial Begins in Germany
Trent Reutiman Named CEO
Archives
Contact
/
Think outside the lumen
MedTech Strategist Nov 27, 2017
Home
/
About Us
/
Corporate Mission
Officers and Directors
Products
/
Bullfrog Micro-Infusion Device
Blowfish Transbronchial Micro-Infusion Device
Science and Technology
/
Peripheral Artery Disease
Bronchial Carcinoma
Peer-Reviewed Publications
Clinical Trials
/
TANGO
LIMBO
DANCE
BROADWAY
Other Trials
News
/
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris
MedTech Strategist Nov 27, 2017
Mercator MedSystems Announces Completion of Enrollment in the LIMBO-ATX Trial
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at ISET and LINC
Mercator Bullfrog Device Being Used in New Proteon Therapeutics Study
Late-Breaking Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at VIVA 2016
LIMBO-ATX Trial Begins in United States
LIMBO-PTA Trial Begins in Germany
Trent Reutiman Named CEO
Archives
Contact
/
(click coverpage to download article)
Home
/
About Us
/
Corporate Mission
Officers and Directors
Products
/
Bullfrog Micro-Infusion Device
Blowfish Transbronchial Micro-Infusion Device
Science and Technology
/
Peripheral Artery Disease
Bronchial Carcinoma
Peer-Reviewed Publications
Clinical Trials
/
TANGO
LIMBO
DANCE
BROADWAY
Other Trials
News
/
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris
MedTech Strategist Nov 27, 2017
Mercator MedSystems Announces Completion of Enrollment in the LIMBO-ATX Trial
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at ISET and LINC
Mercator Bullfrog Device Being Used in New Proteon Therapeutics Study
Late-Breaking Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at VIVA 2016
LIMBO-ATX Trial Begins in United States
LIMBO-PTA Trial Begins in Germany
Trent Reutiman Named CEO
Archives
Contact
/
Mercator MedSystems
Latest News:
Mercator Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceutical Co.
Mercator MedSystems Announces Completion of Enrollment in the LIMBO-ATX Trial
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Clinical Trial Data Presented from Mercator MedSystems' DANCE Trial at ISET and LINC
